Navigation Links
Skinvisible Signs Marketing Agreement for India
Date:12/6/2007

Avani to Represent Dermatology Products Featuring Invisicare(R)

LAS VEGAS, Dec. 6 /PRNewswire-FirstCall/ -- Skinvisible, Inc. (OTC Bulletin Board: SKVI) / (Website: http://www.skinvisible.com), is pleased to announce that it has signed a marketing agreement with Avani International for India. This follows Skinvisible's recent announcement that it was granted a comprehensive patent in India for Skinvisible's proprietary polymer delivery system, Invisicare. Invisicare enhances the delivery of topical dermatology products on the skin.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030416/LAW068LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20040503/INVISICARELOGO)

The agreement with Avani is part of Skinvisible's continued strategy to quickly expand its reach around the globe. Avani will seek licenses in India for topical products Skinvisible has developed for the treatment of acne, fungal infections, atopic dermatitis and hand sanitizers. They will also facilitate clinical studies and manufacturing in India.

"It is important for Skinvisible to develop partnerships with companies such as Avani as they have established relationships with pharmaceutical and consumer goods companies in India. This helps us fast track our marketing efforts in the country and generate license fees and royalties quicker than marketing in India ourselves," said Mr. Terry Howlett, President and CEO of Skinvisible Inc.

"India and its expanding population of over 1 billion people offers tremendous market opportunities for Skinvisible and its Invisicare technology and products," said Ash Chawla, Chairman & CEO of Avani. "This agreement allows us to introduce Invisicare to Indian pharmaceutical manufacturers that we know need this technology."

About Invisicare(R)

Skinvisible has patented its technology and trademarked its polymer delivery system Invisicare(R). Invisicare is a combination of hydrophilic and hydrophobic polymers that hold active ingredients on the skin for extended periods of time. They are non-occlusive and allow normal skin respiration and perspiration while moisturizing and protecting against exposure from a wide variety of environmental irritants. See: http://www.Invisicare.com

About Skinvisible Pharmaceuticals, Inc.

Skinvisible Pharmaceuticals is a research-and-development company whose primary business objective is to license its proprietary formulations with Invisicare(R) to pharmaceutical and cosmeceutical companies as well as assisting companies in revitalizing or enhancing their existing skin care products. Skinvisible receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the Invisicare patent. See: http://www.skinvisible.com

About Avani International

Avani International is a leading business development firm, with services ranging from product commercialization to launch, marketing, sales, and distribution for pharmaceutical, biotechnology and medical device industries. Avani enjoys strong relationships with manufacturers in India and has pioneered relations and business growth between US and Indian companies for the past five years. See: http://www.avaniinternational.com

Forward-Looking Statements

This press release contains 'forward looking' statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10Q for the quarter ending September 30, 2007)

Corporate Contact:

Terry Howlett, President/CEO

Skinvisible Pharmaceuticals, Inc.

Phone: 702-433-7154

Email: info@skinvisible.com


'/>"/>
SOURCE Skinvisible, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Skinvisible to Present at Merriman Curhan Ford & Co.s Investor Summit 2007
2. Skinvisible Appoints Dr. George Korkos to Its Advisory Board
3. Pot bellies linked to early signs of cardiovascular disease
4. MSU engineering team designs innovative medical device
5. Jump in Youth Suicide Prompts National Childrens Charity KidsPeace to Issue Tips on Prevention, Warning Signs
6. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
7. Gov. Blagojevich Signs Bill Improving Illinois Mental Illness Treatment Law
8. A new technology for cancer screening listens for the signs of cancer
9. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
10. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
11. Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... ... California and Nevada and LABS, Inc., announced the future opening of a CLIA ... screening and serology testing used to determine the suitability of potential organ ...
(Date:3/22/2017)... ... ... Wash Tower Ltd. has released a series of six viral poo-related teaser ... standalone constant pressure bidet. , The videos in the series titled "The Adventures of ... well as on its social media pages. , Each video stars Arthur the Butler ...
(Date:3/22/2017)... ... 2017 , ... The Rett Syndrome Research Trust (RSRT) announced ... afflicts 350,000 individuals worldwide. Rett Syndrome is caused by alterations in a ... Following a normal infancy, Rett Syndrome takes effect in toddlerhood depriving children ...
(Date:3/22/2017)... ... 2017 , ... Drs. Jennifer Houck, Lauren Smith, Heather Johnson and the India ... need of skilled pediatric dentistry in Rock Hill, SC, without a referral. ... treatments, including cavities, sealants and fluoride applications, in a comfortable and fun environment. , ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... entered into a research collaboration to translate advances in basic neuroscience at the ... Blythedale and beyond. The collaboration seeks to improve movement, vision, and cognition impaired by ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... solutions, today reported financial and operational results for ... 31, 2016. 2016 Highlights ... compared to the full year 2015  ... year  Direct-to-consumer model launched in ...
(Date:3/22/2017)... today announced the appointment of Martyn Coombs as Chief ... ImaginAb, said "At ImaginAb we have exciting science and technology. Martyn ... business, particularly in commercializing and making step changes in the value ... our potential." ... Coombs is a recognized industry leader in nuclear medicine and imaging. ...
(Date:3/22/2017)... -- Ablation is the minimally invasive therapeutic tissue excision ... from cancerous or diseased tissue removal, to the ... fibrillation and others. The growing adoption of minimally ... and improvise existing ablation technologies for better patient ... is expected to grow at high single digit ...
Breaking Medicine Technology: